Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials

Author:   Mark Chang (Boston University, USA) ,  John Balser ,  Jim Roach ,  Robin Bliss
Publisher:   Taylor & Francis Ltd
ISBN:  

9781032093505


Pages:   376
Publication Date:   30 June 2021
Format:   Paperback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $96.99 Quantity:  
Add to Cart

Share |

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials


Add your own review!

Overview

Full Product Details

Author:   Mark Chang (Boston University, USA) ,  John Balser ,  Jim Roach ,  Robin Bliss
Publisher:   Taylor & Francis Ltd
Imprint:   Chapman & Hall/CRC
Weight:   0.535kg
ISBN:  

9781032093505


ISBN 10:   1032093501
Pages:   376
Publication Date:   30 June 2021
Audience:   College/higher education ,  General/trade ,  Tertiary & Higher Education ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Reviews

This is the first edition of a comprehensive book covering the most recent methodology on innovative clinical trial designs for drugs and biological products. It is a great reference book for statisticians, clinicians, and other stakeholders involved in drug discovery and development. ... Chang et al aimed to provide the statistical framework to reach the overall development program optimizations in this book. In addition, innovative methodology to mitigate the risks of failed efficacy, safety, strategy, commercial and operation failures have been described by Chang et al. Special techniques such as clinical trial simulations are highly recommended by the authors. .... In summary, this is an excellent reference book for statisticians, clinicians, and all stakeholders involved in clinical development program with a common goal to reach clinical development optimization. -Holly Huang in the Journal of Biopharmaceutical Statistics, October 2019 The book has a number of detailed examples, and SAS and R code to implement some of the methods described in the text...In summary, this book covers a wide range of interesting topics in clinical trials, and provides an appealing and useful reference to researchers. - Ionut Bebu, JASA 2020 This first edition of this book provides the most recent methodology and statistical considerations in the design and management of clinical trials. It is focused on professionals in drug development, specifically statisticians and clinical researchers...It is, however, a useful insight into strategies for specific situations including personalized medicine, missing data, adaptive design, and multiple testing. The authors include a large number of practical clinical trials from various therapeutic areas, and they put emphasis on the use of clinical trial simulations...The authors present a remarkable amount of SAS code examples that could be directly used in daily practice. An extensive overview of modern innovative strategies for clinical trials helps to broaden the horizons of scientists interested in drug or treatment development. - Iveta Selingerova, ISCB News, July 2020


""This is the first edition of a comprehensive book covering the most recent methodology on innovative clinical trial designs for drugs and biological products. It is a great reference book for statisticians, clinicians, and other stakeholders involved in drug discovery and development. ... Chang et al aimed to provide the statistical framework to reach the overall development program optimizations in this book. In addition, innovative methodology to mitigate the risks of failed efficacy, safety, strategy, commercial and operation failures have been described by Chang et al. Special techniques such as clinical trial simulations are highly recommended by the authors. .... In summary, this is an excellent reference book for statisticians, clinicians, and all stakeholders involved in clinical development program with a common goal to reach clinical development optimization.” —Holly Huang in the Journal of Biopharmaceutical Statistics, October 2019 ""The book has a number of detailed examples, and SAS and R code to implement some of the methods described in the text...In summary, this book covers a wide range of interesting topics in clinical trials, and provides an appealing and useful reference to researchers."" - Ionut Bebu, JASA 2020 ""This first edition of this book provides the most recent methodology and statistical considerations in the design and management of clinical trials. It is focused on professionals in drug development, specifically statisticians and clinical researchers...It is, however, a useful insight into strategies for specific situations including personalized medicine, missing data, adaptive design, and multiple testing. The authors include a large number of practical clinical trials from various therapeutic areas, and they put emphasis on the use of clinical trial simulations...The authors present a remarkable amount of SAS code examples that could be directly used in daily practice. An extensive overview of modern innovative strategies for clinical trials helps to broaden the horizons of scientists interested in drug or treatment development."" - Iveta Selingerová, ISCB News, July 2020


This is the first edition of a comprehensive book covering the most recent methodology on innovative clinical trial designs for drugs and biological products. It is a great reference book for statisticians, clinicians, and other stakeholders involved in drug discovery and development. ... Chang et al aimed to provide the statistical framework to reach the overall development program optimizations in this book. In addition, innovative methodology to mitigate the risks of failed efficacy, safety, strategy, commercial and operation failures have been described by Chang et al. Special techniques such as clinical trial simulations are highly recommended by the authors. .... In summary, this is an excellent reference book for statisticians, clinicians, and all stakeholders involved in clinical development program with a common goal to reach clinical development optimization. -Holly Huang in the Journal of Biopharmaceutical Statistics, October 2019 The book has a number of detailed examples, and SAS and R code to implement some of the methods described in the text...In summary, this book covers a wide range of interesting topics in clinical trials, and provides an appealing and useful reference to researchers. - Ionut Bebu, JASA 2020 This first edition of this book provides the most recent methodology and statistical considerations in the design and management of clinical trials. It is focused on professionals in drug development, specifically statisticians and clinical researchers...It is, however, a useful insight into strategies for specific situations including personalized medicine, missing data, adaptive design, and multiple testing. The authors include a large number of practical clinical trials from various therapeutic areas, and they put emphasis on the use of clinical trial simulations...The authors present a remarkable amount of SAS code examples that could be directly used in daily practice. An extensive overview of modern innovative strategies for clinical trials helps to broaden the horizons of scientists interested in drug or treatment development. - Iveta Selingerova, ISCB News, July 2020


Author Information

Mark Chang, John Balser, Jim Roach, Robin Bliss

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List